Methadone - Recordati

Drug Profile

Methadone - Recordati

Alternative Names: Methadone chlorhydrate AP HP

Latest Information Update: 24 Nov 2015

Price : $50

At a glance

  • Originator Recordati
  • Class Drug withdrawal therapies; Ketones; Opioid analgesics
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Opioid abuse
  • Preregistration Cancer pain

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 16 Sep 2015 Preregistration for Cancer pain in France (PO) prior to September 2015
  • 31 May 2014 Recordati completes the phase III EQUIMETH2 trial in Cancer pain in France (NCT01793480; EudraCT2011-004609-26)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top